Health And Medicine
-
Vanderbilt awarded NIH grant to continue mentoring and career training among biomedical research graduate students from underrepresented groups
The Vanderbilt School of Medicine Basic Sciences has won continued funding from the National Institutes of Health for its Initiative for Maximizing Student Diversity program supporting the success of biomedical graduate students from underrepresented backgrounds. Read MoreDec 1, 2020
-
Hot spots identified for colorectal cancer mortality rates among young women
Women diagnosed with early-onset colorectal cancer have a greater risk of dying from the disease depending upon their county of residence, according to a study published in Clinical and Translational Gastroenterology. Read MoreNov 23, 2020
-
Ridner returns to cancer patient research and care during Research Ramp-up to advance intervention studies
When in-person research activities at Vanderbilt were put on hold in mid-March due to the COVID-19 pandemic, nursing professor Sheila Ridner’s steadfast commitment to patients ensured that their care did not suffer. Read MoreNov 20, 2020
-
Vanderbilt researchers bring paradigm-shifting technology to endoscopic procedures
Modernized endoscopic system blends robotics and magnetic coupling to improve medical procedures, starting with colonoscopies. Read MoreNov 19, 2020
-
Why does COVID-19 seem to spare children? Vanderbilt University Medical Center study offers an answer
Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. Read MoreNov 18, 2020
-
New drug for metastatic colorectal cancer enters phase 3 trial
A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center. Read MoreNov 18, 2020
-
Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease
Further research by biochemistry professors Charles Sanders and Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research. Read MoreNov 17, 2020
-
Vanderbilt researchers work to build a molecular Trojan horse to battle COVID-19
Vanderbilt biochemists figure out how the little-understood Envelope protein helps SARS-CoV-2 function and how to disrupt the endogenously creative virus. Read MoreNov 17, 2020
-
Younger parents less likely to vaccinate their children and themselves against COVID-19
Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19. Read MoreNov 16, 2020
-
Vanderbilt contributes to the ‘Google Earth’ of the human body, starting with the kidney
Vanderbilt contributes molecular imaging data of kidney to the Human BioMolecular Atlas Program, a consortium of 18 diverse collaborative research teams across the United States and Europe. Read MoreNov 12, 2020
-
New therapeutic target for lung cancer
Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer. Read MoreNov 12, 2020
-
Breast cancer treatment in older women
A new study from Vanderbilt epidemiologists suggests that it’s time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women. Read MoreNov 12, 2020
-
Virtual discussion on the future of health policy scheduled for Nov. 16
Vanderbilt University Medical Center health policy experts share what’s next for drug policy, insurance coverage, health care access and pandemic response in a free virtual discussion on Monday, Nov. 16. Read MoreNov 11, 2020
-
Study underscores importance of personalized medicine in kidney cancer
A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions. Read MoreNov 10, 2020
-
Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes. Read MoreNov 9, 2020
-
Vanderbilt biologist uses rabies-like virus to illuminate how SARS-CoV-2 blocks immune response
Yi Ren, assistant professor of biochemistry, has contributed to research on the function and impact of the SARS-CoV-2 protein on immune signaling protein in host cells. This understanding may lead to the development of immune-enhancing therapeutics. Read MoreNov 9, 2020
-
Ren’s lab advances SARS-CoV-2 research and prioritizes safety during Research Ramp-up
Assistant Professor of Biochemistry Yi Ren and her team have made several discoveries to illuminate the mechanisms of key host-pathogen interactions involving viruses, with implications for gaining a better understanding of SARS-CoV-2, the virus that causes COVID-19. Read MoreNov 6, 2020
-
Nancy Carrasco’s pioneering public health work recognized with National Academy of Medicine election
Nancy Carrasco, professor and chair of the Department of Molecular Physiology and Biophysics and the Joe C. Davis Chair of Biomedical Science, receives one of the highest honors in health and medicine. Read MoreNov 4, 2020
-
Velma McBride Murry’s pathbreaking family intervention work recognized with National Academy of Medicine election
Velma McBride Murry, University Professor of Health Policy and Human & Organizational Development, receives one of the highest honors in health and medicine. Read MoreNov 4, 2020
-
Spontaneous release of neurotransmitters in the brain identified as a culprit of developmental disorders in infants and children
Vanderbilt researchers discover how a group of neurodevelopmental disorders ranging in severity are caused in infants and children, opening new avenues for therapeutics. Read MoreNov 3, 2020